Silence Company

USPTO Has Granted a Notice of Allowance to Silence Therapeutics
Nov 27, 2012
The US Patent and Trademark Office(USPTO)has granted a Notice of Allowance(NOA)to Silence Therapeutics for claims related to interfering RNA molecules and lipid complexes used in drug delivery. The NOA,which is issued based on the ...

Tags: Silence Therapeutics, RNAi therapeutics, Silence Company, RNA molecules